AlphaFold 3 takes structure predictions well beyond proteins
The latest version of Google DeepMind and Isomorphic Labs’ AlphaFold model can predict the structure and relationships not only of proteins, but “all of life’s molecules”,
Report warns economic instability has hit UK drug discovery
A UK report has said that inflation and geopolitical instability have led to a “dramatic drop” in investment in smaller companies developing new medicines, with a knock-on
New metric predicts burden of participating in trials
After patients enrol in clinical trials, regular assessments and testing – often requiring clinic visits – can become onerous and reduce the chances they will stick with t
Spectral AI nears first sales of wound care system
Spectral AI is on the brink of becoming a commercial-stage company, with the first sales of its DeepView wound imaging system due to start in its first market, the UK, lat
Regeneron gene therapy restores hearing in deaf child
Regeneron’s gene therapy for otoferlin-related hearing loss – a genetic cause of deafness – has restored hearing to normal levels in one profoundly deaf child within just
Partner Content
Word Monster and the PM Society Join Forces to Elevate Medic...
The PM Society and Word Monster are joining forces in a new partnership focusing on raising standards and nurturing talent in the MedComms industry.
4th Next Generation Gene Therapy Vectors Summit 2024
Accelerate your capsid and payload design with the 4th Next Generation Gene Therapy Vectors Summit (June 12-14, Boston), the industry’s only hub for covering the latest advances and innovations in
2nd ADC Toxicity Summit 2024
Improving Prediction & Translation of ADC Toxicities to Drive More Tolerable ADCs Successfully Into & Through Clinical Development
15th World Bispecific Summit 2024
Radically Optimize Bi, Tri & Multispecific Antibodies to Enhance Target Discovery, Mechanistic Diversity & Clinical Translation to Maximize the Therapeutic Index & Enhance Combi
9th Microbiome Movement Drug Development Summit
The Home of Accelerating Microbial-Based Drug Development